In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Research on Human Fetal Tissue 
Amendments of 1993''.

SEC. 2. ESTABLISHMENT OF AUTHORITIES AND PROTECTIONS REGARDING 
              TRANSPLANTATION OF HUMAN FETAL TISSUE.

    Part G of title IV of the Public Health Service Act (42 U.S.C. 289 
et seq.) is amended by inserting after section 498 the following new 
section:

             ``research on transplantation of fetal tissue

    ``Sec. 498A. (a) Establishment of Program.--
            ``(1) In general.--The Secretary may conduct or support 
        research on the transplantation of human fetal tissue for 
        therapeutic purposes.
            ``(2) Source of tissue.--Human fetal tissue may be used in 
        research carried out under paragraph (1) regardless of whether 
        the tissue is obtained pursuant to a spontaneous or induced 
        abortion or pursuant to a stillbirth.
    ``(b) Informed Consent of Donor.--
            ``(1) In general.--In research carried out under subsection 
        (a), human fetal tissue may be used only if the woman providing 
        the tissue makes a statement, made in writing and signed by the 
        woman, declaring that--
                    ``(A) the woman donates the fetal tissue for use in 
                research described in subsection (a);
                    ``(B) the donation is made without any restriction 
                regarding the identity of individuals who may be the 
                recipients of transplantations of the tissue; and
                    ``(C) the woman has not been informed of the 
                identity of any such individuals.
            ``(2) Additional statement.--In research carried out under 
        subsection (a), human fetal tissue may be used only if the 
        attending physician with respect to obtaining the tissue from 
        the woman involved makes a statement, made in writing and 
        signed by the physician, declaring that--
                    ``(A) in the case of tissue obtained pursuant to an 
                induced abortion--
                            ``(i) the consent of the woman for the 
                        abortion was obtained prior to requesting or 
                        obtaining consent for the tissue to be used in 
                        such research; and
                            ``(ii) no alteration of the timing, method, 
                        or procedures used to terminate the pregnancy 
                        was made solely for the purposes of obtaining 
                        the tissue;
                    ``(B) the tissue has been donated by the woman in 
                accordance with paragraph (1); and
                    ``(C) full disclosure has been provided to the 
                woman with regard to--
                            ``(i) such physician's interest, if any, in 
                        the research to be conducted with the tissue; 
                        and
                            ``(ii) any known medical risks to the woman 
                        or risks to her privacy that might be 
                        associated with the donation of the tissue and 
                        that are in addition to risks of such type that 
                        are associated with the woman's medical care.
    ``(c) Informed Consent of Researcher and Donee.--In research 
carried out under subsection (a), human fetal tissue may be used only 
if the individual with the principal responsibility for conducting the 
research involved makes a statement, made in writing and signed by the 
individual, declaring that the individual--
            ``(1) is aware that--
                    ``(A) the tissue is human fetal tissue;
                    ``(B) the tissue may have been obtained pursuant to 
                a spontaneous or induced abortion or subsequent to a 
                stillbirth; and
                    ``(C) the tissue was donated for research purposes;
            ``(2) has provided such information to other individuals 
        with responsibilities regarding the research;
            ``(3) will require, prior to obtaining the consent of an 
        individual to be a recipient of a transplantation of the 
        tissue, written acknowledgment of receipt of such information 
        by such recipient; and
            ``(4) has had no part in any decisions as to the timing, 
        method, or procedures used to terminate the pregnancy made 
        solely for the purposes of the research.
    ``(d) Availability of Statements for Audit.--
            ``(1) In general.--In research carried out under subsection 
        (a), human fetal tissue may be used only if the head of the 
        agency or other entity conducting the research involved 
        certifies to the Secretary that the statements required under 
        subsections (b)(2) and (c) will be available for audit by the 
        Secretary.
            ``(2) Confidentiality of audit.--Any audit conducted by the 
        Secretary pursuant to paragraph (1) shall be conducted in a 
        confidential manner to protect the privacy rights of the 
        individuals and entities involved in such research, including 
        such individuals and entities involved in the donation, 
        transfer, receipt, or transplantation of human fetal tissue. 
        With respect to any material or information obtained pursuant 
        to such audit, the Secretary shall--
                    ``(A) use such material or information only for the 
                purposes of verifying compliance with the requirements 
                of this section;
                    ``(B) not disclose or publish such material or 
                information, except where required by Federal law, in 
                which case such material or information shall be coded 
                in a manner such that the identities of such 
                individuals and entities are protected; and
                    ``(C) not maintain such material or information 
                after completion of such audit, except where necessary 
                for the purposes of such audit.
    ``(e) Applicability of State and Local Law.--
            ``(1) Research conducted by recipients of assistance.--The 
        Secretary may not provide support for research under subsection 
        (a) unless the applicant for the financial assistance involved 
        agrees to conduct the research in accordance with applicable 
        State and local law.
            ``(2) Research conducted by secretary.--The Secretary may 
        conduct research under subsection (a) only in accordance with 
        applicable State and local law.
    ``(f) Definition.--For purposes of this section, the term `human 
fetal tissue' means tissue or cells obtained from a dead human embryo 
or fetus after a spontaneous or induced abortion, or after a 
stillbirth.''.

SEC. 3. PURCHASE OF HUMAN FETAL TISSUE; SOLICITATION OR ACCEPTANCE OF 
              TISSUE AS DIRECTED DONATION FOR USE IN TRANSPLANTATION.

    Part G of title IV of the Public Health Service Act, as amended by 
section 2 of this Act, is amended by inserting after section 498A the 
following new section:

              ``prohibitions regarding human fetal tissue

    ``Sec. 498B. (a) Purchase of Tissue.--It shall be unlawful for any 
person to knowingly acquire, receive, or otherwise transfer any human 
fetal tissue for valuable consideration if the transfer affects 
interstate commerce.
    ``(b) Solicitation or Acceptance of Tissue as Directed Donation for 
Use in Transplantation.--It shall be unlawful for any person to solicit 
or knowingly acquire, receive, or accept a donation of human fetal 
tissue for the purpose of transplantation of such tissue into another 
person if the donation affects interstate commerce, the tissue will be 
or is obtained pursuant to an induced abortion, and--
            ``(1) the donation will be or is made pursuant to a promise 
        to the donating individual that the donated tissue will be 
        transplanted into a recipient specified by such individual;
            ``(2) the donated tissue will be transplanted into a 
        relative of the donating individual; or
            ``(3) the person who solicits or knowingly acquires, 
        receives, or accepts the donation has provided valuable 
        consideration for the costs associated with such abortion.
    ``(c) Criminal Penalties for Violations.--
            ``(1) In general.--Any person who violates subsection (a) 
        or (b) shall be fined in accordance with title 18, United 
        States Code, subject to paragraph (2), or imprisoned for not 
        more than 10 years, or both.
            ``(2) Penalties applicable to persons receiving 
        consideration.--With respect to the imposition of a fine under 
        paragraph (1), if the person involved violates subsection (a) 
        or (b)(3), a fine shall be imposed in an amount not less than 
        twice the amount of the valuable consideration received.
    ``(d) Definitions.--For purposes of this section:
            ``(1) The term `human fetal tissue' has the meaning given 
        such term in section 498A(f).
            ``(2) The term `interstate commerce' has the meaning given 
        such term in section 201(b) of the Federal Food, Drug, and 
        Cosmetic Act.
            ``(3) The term `valuable consideration' does not include 
        reasonable payments associated with the transportation, 
        implantation, processing, preservation, quality control, or 
        storage of human fetal tissue.''.

SEC. 4. REPORT BY GENERAL ACCOUNTING OFFICE ON ADEQUACY OF PROTECTIONS.

    (a) In General.--With respect to research on the transplantation of 
human fetal tissue for therapeutic purposes, the Comptroller General of 
the United States shall conduct an audit for the purpose of 
determining--
            (1) whether and to what extent such research conducted or 
        supported by the Secretary of Health and Human Services has 
        been conducted in accordance with section 498A of the Public 
        Health Service Act (as added by section 2 of this Act); and
            (2) whether and to what extent there have been violations 
        of section 498B of such Act (as added by section 3 of this 
        Act).
    (b) Report.--Not later than May 19, 1995, the Comptroller General 
of the United States shall complete the audit required in subsection 
(a) and submit to the Congress a report describing the findings made 
pursuant to the audit.
[EX A]: Research on Human Fetal Tissue Amendments of 1993 - Amends the Public Health Service Act to authorize and regulate research on human fetal tissue transplantation without regard to whether the tissue is obtained after a spontaneous or induced abortion or a stillbirth in accordance with State law. 
Imposes criminal penalties for:  (1) transferring such tissue for valuable consideration affecting interstate commerce; or (2) soliciting or receiving a directed donation.

[EX Q]: SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Emergency 
Unemployment Compensation Act of 2002''.
    (b) Table of Contents.--The table of contents of this Act is as 
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Extension of the Temporary Extended Unemployment Compensation 
                            Act of 2002.
Sec. 3. Entitlement to additional weeks of temporary extended 
                            unemployment compensation.
Sec. 4. Application of revised rate of insured unemployment.
Sec. 5. Additional TEUC extended benefit period trigger.
Sec. 6. Additional weeks of benefits for workers in high unemployment 
                            States.
Sec. 7. Effective date.

SEC. 2. EXTENSION OF THE TEMPORARY EXTENDED UNEMPLOYMENT COMPENSATION 
              ACT OF 2002.

    (a) Six-Month Extension of Program.--Section 208 of the Temporary 
Extended Unemployment Compensation Act of 2002 (Public Law 107-147; 116 
Stat. 30) is amended to read as follows:

``SEC. 208. APPLICABILITY.

    ``(a) In General.--Subject to subsection (b), an agreement entered 
into under this title shall apply to weeks of unemployment--
            ``(1) beginning after the date on which such agreement is 
        entered into; and
            ``(2) ending before July 1, 2003.
    ``(b) Transition.--In the case of an individual who is receiving 
temporary emergency unemployment compensation for the week which 
immediately precedes July 1, 2003, temporary emergency unemployment 
compensation shall continue to be payable to such individual for any 
week thereafter from the account from which such individual received 
compensation for the week which includes such termination date. No 
compensation shall be payable by reason of the preceding sentence for 
any week beginning after October 14, 2003.''.
    (b) Effective Date.--The amendment made by this section shall take 
effect as if included in the enactment of the Temporary Extended 
Unemployment Compensation Act of 2002 (Public Law 107-147; 116 Stat. 
21).

SEC. 3. ENTITLEMENT TO ADDITIONAL WEEKS OF TEMPORARY EXTENDED 
              UNEMPLOYMENT COMPENSATION.

    Paragraph (1) of section 203(b) of the Temporary Extended 
Unemployment Compensation Act of 2002 (Public Law 107-147; 116 Stat. 
21) is amended to read as follows:
            ``(1) In general.--The amount established in an account 
        under subsection (a) shall be equal to 26 times the 
        individual's weekly benefit amount for the benefit year.''.

SEC. 4. APPLICATION OF REVISED RATE OF INSURED UNEMPLOYMENT.

    Section 207 of the Temporary Extended Unemployment Compensation Act 
of 2002 (Public Law 107-147; 116 Stat. 21) is amended--
            (1) by striking ``In this title, the terms'' and inserting 
        the following: ``In this title:
            ``(1) General definitions.--The terms''; and
            (2) by adding at the end the following new paragraph:
            ``(2) Adjusted insured unemployment rate.--For weeks of 
        unemployment beginning on or after the date of enactment of the 
        Emergency Unemployment Compensation Act of 2002, the term `rate 
        of insured unemployment' has the meaning given that term in 
        section 203(e)(1) of the Federal-State Extended Unemployment 
        Compensation Act of 1970 (26 U.S.C. 3304 note), except that 
        individuals exhausting their right to regular compensation 
        during the most recent 3 calendar months for which data are 
        available before the close of the period for which such rate is 
        being determined shall be taken into account as if they were 
        individuals filing claims for regular compensation for each 
        week during the period for which such rate is being 
        determined.''.

SEC. 5. ADDITIONAL TEUC EXTENDED BENEFIT PERIOD TRIGGER.

    (a) In General.--Section 203(c) of the Temporary Extended 
Unemployment Compensation Act of 2002 (Public Law 107-147; 116 Stat. 
21) is amended by adding at the end the following new paragraph:
            ``(3) Additional extended benefit period trigger.--
                    ``(A) In general.--Effective with respect to 
                compensation for weeks of unemployment beginning on or 
                after the date of enactment of the Emergency 
                Unemployment Compensation Act of 2002, an agreement 
                under this title shall provide that, in addition to any 
                other extended benefit period trigger, for purposes of 
                beginning or ending any extended benefit period under 
                this section--
                            ``(i) there is a State `on' indicator for a 
                        week if--
                                    ``(I) the average rate of total 
                                unemployment in such State (seasonally 
                                adjusted) for the period consisting of 
                                the most recent 3 months for which data 
                                for all States are published before the 
                                close of such week equals or exceeds 6 
                                percent; and
                                    ``(II) the average rate of total 
                                unemployment in such State (seasonally 
                                adjusted) for the 3-month period 
                                referred to in clause (i) equals or 
                                exceeds 110 percent of such average 
                                rate for either (or both) of the 
                                corresponding 3-month periods ending in 
                                the 2 preceding calendar years; and
                            ``(ii) there is a State `off' indicator for 
                        a week if either the requirements of subclause 
                        (I) or (II) of clause (i) are not satisfied.
                    ``(B) No effect on other determinations.--
                Notwithstanding the provisions of any agreement 
                described in subparagraph (A), any week for which there 
                would otherwise be a State `on' indicator shall 
                continue to be such a week and shall not be determined 
                to be a week for which there is a State `off' 
                indicator.
                    ``(C) Determinations made by the secretary.--For 
                purposes of this subsection, determinations of the rate 
                of total unemployment in any State for any period (and 
                of any seasonal adjustment) shall be made by the 
                Secretary.''.
    (b) Conforming Amendment.--Section 203(c)(1) of the Temporary 
Extended Unemployment Compensation Act of 2002 (Public Law 107-147; 116 
Stat. 21) is amended by inserting ``or (3)'' after ``paragraph (2)''.

SEC. 6. ADDITIONAL WEEKS OF BENEFITS FOR WORKERS IN HIGH UNEMPLOYMENT 
              STATES.

    Section 203(c)(1) of the Temporary Extended Unemployment 
Compensation Act of 2002 (Public Law 107-147; 116 Stat. 30) is amended 
by striking ``an amount equal to the amount originally established in 
such account (as determined under subsection (b)(1))'' and inserting 
``7 times the individual's weekly benefit amount for the benefit 
year''.

SEC. 7. EFFECTIVE DATE.

    Except as otherwise provided in this Act, the amendments made by 
this Act shall apply with respect to weeks of unemployment beginning on 
or after the date of enactment this Act.
[EX A]: Emergency Unemployment Compensation Act of 2002 - Amends the Temporary Extended Unemployment Compensation Act of 2002 (TEUCA, which is title II of the Job Creation and Worker Assistance Act of 2002, PL107-147) to extend the TEUCA program through weeks of unemployment ending before July 1, 2003 (currently January 1, 2003).Entitles eligible individuals in all States to a total of 26 weeks of TEUCA compensation (13 weeks beyond the current 13 weeks).Provides an additional seven weeks of TEUCA benefits for workers in high unemployment States (entitling them to a total of 33, which is 20 weeks beyond the current 13).Applies a revised adjusted insured unemployment rate State trigger. Sets an additional TEUCA benefit period State trigger based on total unemployment rate.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Arrest Methamphetamine Act of 
2005''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Methamphetamine (meth) is an extremely dangerous and 
        highly addictive drug.
            (2) Methamphetamine use contributes to the perpetration of 
        violent crimes, particularly burglary, child abuse, and crimes 
        of substantial cost and personal pain to the victims, including 
        identity theft.
            (3) Methamphetamine labs produce hazardous conditions 
        because of their use of chemicals such as anhydrous ammonia, 
        ether, sulfuric acid, and other toxins which are volatile, 
        corrosive and poisonous. When these substances are illegally 
        disposed of in rivers, streams, and other dump areas, 
        explosions and serious environmental damage can and does 
        result.
            (4) Since 2001, Federal funding has been provided through 
        the Department of Justice COPS and Byrne Grant programs to 
        address methamphetamine enforcement and clean up. Since 2002, 
        although the methamphetamine problem has been growing and 
        spreading across the United States, COPS funding has been cut 
        each successive year, from $70,500,000 in 2002, to under 
        $52,000,000 in 2005.
            (5) As methamphetamine has impacted more States each year, 
        the dwindling Federal funds have been parsed into smaller 
        amounts. Each State deserves greater Federal support and a 
        permanent funding mechanism to confront the challenging problem 
        of methamphetamine abuse.
            (6) Permanent Federal funding support for meth enforcement 
        and clean-up is critical to the efforts of State and local law 
        enforcement to reduce the use, manufacture, and sale of 
        methamphetamine, and thus, reduce the crime rate.
            (7) It is necessary for the Federal Government to establish 
        a long-term commitment to confronting methamphetamine use, 
        sale, and manufacture by creating a permanent funding mechanism 
        to assist States.

SEC. 3. CONFRONTING THE USE OF METHAMPHETAMINE.

    Title I of the Omnibus Crime Control and Safe Streets Act of 1968 
(42 U.S.C. 3711 et seq.) is amended by adding at the end the following:

             ``PART HH--CONFRONTING USE OF METHAMPHETAMINE

``SEC. 2991. AUTHORITY TO MAKE GRANTS TO ADDRESS PUBLIC SAFETY AND 
              METHAMPHETAMINE MANUFACTURING, SALE, AND USE.

    ``(a) Purpose and Program Authority.--
            ``(1) Purpose.--It is the purpose of this part to assist 
        States--
                    ``(A) to carry out programs to address the 
                manufacture, sale, and use of methamphetamine drugs; 
                and
                    ``(B) to improve the ability of State and local 
                government institutions of to carry out such programs.
            ``(2) Grant authorization.--The Attorney General, through 
        the Bureau of Justice Assistance in the Office of Justice 
        Programs may make grants to States to address the manufacture, 
        sale, and use of methamphetamine to enhance public safety.
            ``(3) Grant projects to address methamphetamine manufacture 
        sale and use.--Grants made under subsection (a) may be used for 
        programs, projects, and other activities to--
                    ``(A) arrest individuals violating laws related to 
                the use, manufacture, or sale of methamphetamine;
                    ``(B) undertake methamphetamine clandestine lab 
                seizures and environmental clean up;
                    ``(C) provide for community-based education, 
                awareness, and prevention;
                    ``(D) provide child support and family services 
                related to assist users of methamphetamine and their 
                families;
                    ``(E) facilitate intervention in methamphetamine 
                use;
                    ``(F) facilitate treatment for methamphetamine 
                addiction;
                    ``(G) provide Drug Court and Family Drug Court 
                services to address methamphetamine;
                    ``(H) provide community policing to address the 
                problem of methamphetamine use;
                    ``(I) support State and local health department and 
                environmental agency services deployed to address 
                methamphetamine;
                    ``(J) prosecute violations of laws related to the 
                use, manufacture, or sale of methamphetamine; and
                    ``(K) procure equipment, technology, or support 
                systems, or pay for resources, if the applicant for 
                such a grant demonstrates to the satisfaction of the 
                Attorney General that expenditures for such purposes 
                would result in the reduction in the use, sale, and 
                manufacture of methamphetamine.
    ``(b) Eligibility.--To be eligible to receive a grant under this 
part, a State shall submit to the Attorney General assurances that the 
State has implemented, or will implement prior to receipt of a grant 
under this section laws, policies, and programs that restrict the 
wholesale and limit sale of products used as precursors in the 
manufacture of methamphetamine.

``SEC. 2992. APPLICATIONS.

    ``(a) In General.--No grant may be made under this part unless an 
application has been submitted to, and approved by, the Attorney 
General.
    ``(b) Application.--An application for a grant under this part 
shall be submitted in such form, and contain such information, as the 
Attorney General may prescribe by regulation or guidelines.
    ``(c) Contents.--In accordance with the regulations or guidelines 
established by the Attorney General, each application for a grant under 
this part shall--
            ``(1) include a long-term statewide strategy that--
                    ``(A) reflects consultation with appropriate public 
                and private agencies, tribal governments, and community 
                groups;
                    ``(B) represents an integrated approach to 
                addressing the use, manufacture, and sale of 
                methamphetamine that includes--
                            ``(i) arrest and clandestine lab seizure;
                            ``(ii) training for law enforcement, fire 
                        and other relevant emergency services, health 
                        care providers, and child and family service 
                        providers;
                            ``(iii) intervention;
                            ``(iv) child and family services;
                            ``(v) treatment;
                            ``(vi) drug court;
                            ``(vii) family drug court;
                            ``(viii) health department support;
                            ``(ix) environmental agency support;
                            ``(x) prosecution; and
                            ``(xi) evaluation of the effectiveness of 
                        the program and description of the efficacy of 
                        components of the program for the purpose of 
                        establishing best practices that can be widely 
                        replicated by other States; and
                    ``(C) where appropriate, incorporate Indian Tribal 
                participation to the extent that an Indian Tribe is 
                impacted by the use, manufacture, or sale of 
                methamphetamine;
            ``(2) identify related governmental and community 
        initiatives which complement or will be coordinated with the 
        proposal;
            ``(3) certify that there has been appropriate coordination 
        with all affected State and local government institutions and 
        that the State has involved counties and other units of local 
        government, when appropriate, in the development, expansion, 
        modification, operation or improvement of programs to address 
        the use, manufacture, or sale of methamphetamine;
            ``(4) certify that the State will share funds received 
        under this part with counties and other units of local 
        government, taking into account the burden placed on these 
        units of government when they are required to address the use, 
        manufacture, or sale of methamphetamine;
            ``(5) assess the impact, if any, of the increase in police 
        resources on other components of the criminal justice system;
            ``(6) explain how the grant will be utilized to enhance 
        government response to the use, manufacture, and sale of 
        methamphetamine;
            ``(7) demonstrate a specific public safety need;
            ``(8) explain the applicant's inability to address the need 
        without Federal assistance;
            ``(9) specify plans for obtaining necessary support and 
        continuing the proposed program, project, or activity following 
        the conclusion of Federal support; and
            ``(10) certify that funds received under this part will be 
        used to supplement, not supplant, other Federal, State, and 
        local funds.

``SEC. 2993. PLANNING GRANTS.

    ``(a) Eligible Entity.--The Attorney General through the Bureau of 
Justice Assistance in the Office of Justice Programs, may make grants 
under this section to States, Indian tribal governments, and multi-
jurisdictional or regional consortia thereof to develop a 
comprehensive, cooperative strategy to address the manufacture, sale, 
and use of methamphetamine to enhance public safety.
    ``(b) Authorization.--The Attorney General is authorized to provide 
grants under this section not exceeding $100,000 per eligible entity 
for such entity to--
            ``(1) define the problem of the use, manufacture, or sale 
        of methamphetamine within the jurisdiction of the entity;
            ``(2) describe the public and private organization to be 
        involved in addressing methamphetamine use, manufacture, or 
        sale; and
            ``(3) describe the manner in which these organizations will 
        participate in a comprehensive, cooperative, and integrated 
        plan to address the use, manufacture, or sale of 
        methamphetamine.

``SEC. 2994. ENFORCEMENT GRANTS.

    ``Of the total amount appropriated for this part in any fiscal 
year, the amount remaining after setting aside the amount to be 
reserved to carry out section 2993 shall be allocated to States as 
follows:
            ``(1) 0.25 percent or $250,000, whichever is greater, shall 
        be allocated to each of the States.
            ``(2) Of the total funds remaining after the allocation 
        under paragraph (1), there shall be allocated to each State an 
        amount which bears the same ratio to the amount of remaining 
        funds described in this paragraph as the population of such 
        State bears to the population of all the States.

``SEC. 2995. NATIONAL ACTIVITIES.

    ``The Attorney General is authorized--
            ``(1) to collect systematic data on the effectiveness of 
        the programs assisted under this part in reducing the use, 
        manufacture, and sale of methamphetamine;
            ``(2) to establish a national clearinghouse of information 
        on effective programs to address the use, manufacture, and sale 
        of methamphetamine that shall disseminate to State and local 
        agencies describing--
                    ``(A) the results of research on efforts to reduce 
                the use, manufacture, and sale of methamphetamine; and
                    ``(B) information on effective programs, best 
                practices and Federal resources to--
                            ``(i) reduce the use, manufacture, and sale 
                        of methamphetamine; and
                            ``(ii) address the physical, social, and 
                        family problems that result from the use of 
                        methamphetamine through the activities of 
                        intervention, treatment, drug courts, and 
                        family drug courts;
            ``(3) to establish a program within the Department of 
        Justice to facilitate the sharing of knowledge in best 
        practices among States addressing the use, manufacture and sale 
        of methamphetamine through State-to-State mentoring, or other 
        means; and
            ``(4) to provide technical assistance to State agencies and 
        local agencies implementing programs and securing resources to 
        implement effective programs to reduce the use, manufacture, 
        and sale of methamphetamine.

``SEC. 2996. FUNDING.

    ``(a) Grants for the Purpose of Confronting the Use of 
Methamphetamine.--There are authorized to be appropriated to carry out 
this part--
            ``(1) $100,000,000 for each fiscal year 2006 and 2007; and
            ``(2) $200,000,000 for each fiscal year 2008, 2009, and 
        2010.
    ``(b) National Activities.--For the purposes of section 2995, there 
are authorized to be appropriated such sums as are necessary.''.

SEC. 4. STATEMENT OF CONGRESS REGARDING AVAILABILITY AND ILLEGAL 
              IMPORTATION OF PSEUDOEPHEDRINE FROM CANADA.

    (a) Findings.--Congress finds that--
            (1) pseudoephedrine is a particularly abused basic 
        precursor chemical used in the manufacture of the dangerous 
        narcotic methamphetamine;
            (2) the Federal Government, working in cooperation with 
        narcotics agents of State and local governments and the private 
        sector, has tightened the control of pseudoephedrine in the 
        United States in recent years;
            (3) in many States, pseudoephedrine can only be purchased 
        in small quantity bottles or blister packs, and laws throughout 
        various States are gradually becoming tougher, reflecting the 
        increasing severity of America's methamphetamine problem; 
        however, the widespread presence of large containers of 
        pseudoephedrine from Canada at methamphetamine laboratories and 
        dumpsites in the United States, despite efforts of law 
        enforcement agencies to stem the flow of these containers into 
        the United States, demonstrates the strength of the demand for, 
        and the inherent difficulties in stemming the flow of, these 
        containers from neighboring Canada; and
            (4) Canada lacks a comprehensive legislative framework for 
        addressing the pseudoephedrine trafficking problem.
    (b) Call for Action by Canada.--Congress strongly urges the 
President to seek commitments from the Government of Canada to begin 
immediately to take effective measures to stem the widespread and 
increasing availability in Canada and the illegal importation into the 
United States of pseudoephedrine.
[EX A]:
Arrest Methamphetamine Act of 2005 - Amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Attorney General, through the Bureau of Justice Assistance (BJA), to make grants to States to address the manufacture, sale, and use of methamphetamine to enhance public safety, including for activities to: (1) arrest individuals violating methamphetamine related laws; (2) undertake methamphetamine clandestine lab seizures and environmental cleanup; (3) provide for community based education, awareness, and prevention; (4) provide child support and family services to assist methamphetamine users and their families; and (5) procure equipment, technology, or support systems, or pay for resources, where expenditures would result in reduction in methamphetamine use, sale, and manufacture. Sets forth application requirements.

Authorizes the Attorney General, through BJA, to make grants to States, Indian tribal governments, and multijurisdictional or regional consortia to develop a comprehensive, cooperative strategy to address the use, sale, and manufacture of methamphetamine. Allocates funding for enforcement.

Authorizes the Attorney General to: (1) collect systematic data on the effectiveness of programs assisted under this Act; (2) establish a national clearinghouse of information on effective programs for dissemination to State and local agencies; (3) establish a program within the Department of Justice to facilitate the sharing of best practices among States; and (4) provide technical assistance to State and local agencies.

Urges the President to seek commitments from the Canadian Government to take effective measures to stem the availability of pseudoephedrine in Canada and its illegal importation into the United States.